On May 4, 2020 Ribon Therapeutics, a clinical-stage oncology company developing first-in-class therapeutics targeting stress response pathways, reported that Victoria Richon, Ph.D., President and CEO, will present at two upcoming virtual healthcare conferences (Press release, Ribon Therapeutics, MAY 4, 2020, View Source [SID1234556948]). Presentations will consist of a panel discussion and a corporate overview.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
31st Annual Cancer Progress Conference – May 5-6, 2020
Panel: Paradigm-shifting Platforms II, Non-IO: Targeting Better, Targeting the Intractable
Date: May 5, 2020
Time: 11:45 a.m. EDT
Bank of America Securities 2020 HealthCare Conference – May 12-14, 2020
Corporate Presentation
Date: May 12, 2020
Time: 5:00 p.m. EDT